Results 131 to 140 of about 101,012 (310)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy

Asian Journal of Andrology, 2015
External beam radiotherapy (EBRT) is a standard treatment for prostate cancer. Despite the development of novel radiotherapy techniques such as intensity-modulated conformal radiotherapy, the risk of local recurrence after EBRT has not been obviated ...
Yasuhiro Yamada, Koji Okihara, Tsuyoshi Iwata, Koji Masui, Kazumi Kamoi, Kei Yamada, Tsuneharu Miki   +6 more
doaj   +1 more source

Recent developments in brachytherapy [PDF]

Reports of Practical Oncology & Radiotherapy, 2011
Brachytherapy has a long and illustrious history in the treatment of cancer dating back to the early 20th century. Although its popularity has fluctuated in response to the emergence of newer treatment modalities, brachytherapy has persisted over time.
openaire   +3 more sources

The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey

Clinical and Translational Radiation Oncology
A survey regarding utilisation of brachytherapy was distributed to European brachytherapy professionals. Eighty replies from 26 countries were received, two of which were outside Europe. The replies showed that brachytherapy is still widely used.
J.G. Johansen, I.M. Jürgenliemk-Schulz, H. Haddad, J.M. Hannoun-Levi, T.P. Hellebust, B. Guix, K. Loessl, B. Pieters, C. Rao, V. Strnad, A.E. Sturdza, L. Tagliaferri, Z. Takacsi-Nagy, E. Villafranca, P. Wojcieszek, A. Rembielak, P. Niehoff   +16 more
doaj  

Treatment of unresectable carcinoma of pancreas by iodine-125 brachytherapy and external radiation therapy [PDF]

, 1986
Man H. Shiu, Basil S. Hilaris, Murray F. Brennan   +2 more
openalex   +1 more source

Value of Routine Pelvic Examination in the Follow‐Up of Patients Receiving Adjuvant Radiation Therapy for Endometrial Cancer: An Australian Tertiary‐Centre Experience

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Pelvic examination is a routine component of post‐treatment surveillance for endometrial cancer, supported by global guidelines. However, there is no evidence of oncological or quality‐of‐life benefit, with data suggesting associated discomfort and potential psychological harm.
M. C. Knox, A. Salkeld, A. Brand, U. Herbst, J. Chard, N. Thiruthaneeswaran   +5 more
wiley   +1 more source

Focal Spot, Fall/Winter 1992 [PDF]

, 1992
https://digitalcommons.wustl.edu/focal_spot_archives/1062/thumbnail ...

core   +1 more source

The Demographics and Outcomes of Women With Stage II Endometrial Cancer Diagnosed in Australia 2005–2007

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Stage II endometrial cancer comprises 5% to 10% of cases and is pathologically diverse. Retrospective data guides recommendations which suggest surgical staging with adjuvant therapy, but the role of radical surgery and lymphadenectomy is uncertain, due to conflicting outcomes.
Jonathan Sandeford, Pearl Tong, Selvan Pather   +2 more
wiley   +1 more source

Focal Spot, Fall/Winter 1989 [PDF]

, 1989
https://digitalcommons.wustl.edu/focal_spot_archives/1053/thumbnail ...

core   +1 more source

Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe‐GCG) study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
The aim of this study was to evaluate the quality of data in the Swedish Quality Register of Gynecologic Cancer (SQRGC on cervical cancer and vulvar cancer in terms of completeness, timeliness, comparability, and validity according to the International Agency for Research on Cancer methodology.
Maria Bjurberg, Kristina Hellman, Tim A. Säll, Christian Staf, Christer Borgfeldt, Erik Holmberg, Jenny Jönsson, Gabriel Lindahl, Angelique Flöter Rådestad, Camilla Sköld, Katja Stenström Bohlin, Karin Stålberg, Elisabeth Åvall‐Lundqvist, Preben Kjølhede, Pernilla Dahm‐Kähler   +14 more
wiley   +1 more source

Dosimetry characterization of $^{32}$P intravascular brachytherapy source wires using Monte Carlo codes PENELOPE and GEANT4

, 2003
Monte Carlo calculations using the codes PENELOPE and GEANT4 have been performed to characterize the dosimetric parameters of the new 20 mm long catheter based $^{32}$P beta source manufactured by Guidant Corporation.
Agostinelli, Antonio M. Lallena, Asenjo, Bohm, Fox, Garcı́a-Toraño, Javier Torres, Julio F. Almansa, Li, Manuel J. Buades, Mourtada, Mourtada, Nath, Pocock, Pötter, Rafael Guerrero, Schaart, Sehgal, Sánchez-Reyes, Vynckier, Waksman, Wang   +21 more
core   +1 more source